Free Trial
Want deep insights into your competitors & competitive landscape? Try Patsnap Eureka!

Top 10 Startups & Unicorns companies in Bladder cancer
by Highest Patent Value in the United States in 2021

The Bladder cancer top 10 is Discovery PatSnap’ annual ranking of the top 10 Highest Patent Value Bladder cancer Startups & Unicorns in the United States. Discovery has identified the top key players, startups & unicorns, fast-growings, news entrants in 2021, ranking from differnt perspectives, including patent filing intensity, academic research capability, news media heat. The company list is generated from various data types.
#
Company Name
Region
Tech Topics
Total
1
Intrepida Bio, Inc.
Innate immune system,Medicine
Avg patent value: 2.29 M
2
NantOmics LLC
Biology,Cloud database,Medicine,
...[+2]
Avg patent value: 740,000
3
KDx Diagnostics, Inc.
Bladder cancer,Health care,Healthcare industry,
...[+2]
Avg patent value: 350,000
4
Dragonfly Therapeutics, Inc.
Pharmacy and Therapeutics,Biomedicine,Biotechnology,
...[+2]
Avg patent value: 86,000
5
Convergent Genomics, Inc.
Liquid biopsy
Avg patent value: 25,000
6
QED Therapeutics, Inc.
Medicine,Health care,Pharmacy and Therapeutics,
...[+2]
Avg patent value: 17,000
7
ENB Therapeutics, Inc.
Cisplatin,Medicine,Health care,
...[+2]
Avg patent value: 15,000
8
Epivax Oncology, Inc.
Health care,Hospitality industry,Cancer immunotherapy,
...[+2]
Avg patent value: 14,000
9
Caris Life Sciences Ltd.
Health care,Precision medicine,Biotechnology,
...[+2]
Avg patent value: 0
10
Bridge Financial Technology, Inc.
Software,Accounting,Fiduciary
Avg patent value: 0
Page generation time: May 12 2025